Ongoing R&D
CDx Diagnostics has a dedicated team of world-class imaging and artificial intelligence engineers and developers committed to pushing the edge of impossibility to create next-generation diagnostic and histocytology solutions.
Innovative technology that reliably detects dysplasia and makes cancer prevention possible.
Learn MoreStay informed about your health and the benefits of advanced technology that finds precancerous cells.
Learn MoreSample notification text goes here and here.
CDx Diagnostics is committed to helping make cancer a preventable disease through innovative technology – starting with WATS3D for esophageal cancer.
But we’re not stopping there…
CDx Diagnostics is expanding the application of our proprietary technology - developing tests in the digestive tract by adapting the approach of the WATS3D diagnostic platform to detect precancerous changes and prevent cancers of the bile duct, stomach, and colon - cancers with poor prognoses without improved diagnostics to reliably detect precancer before it can progress to cancer.
>5-Year Survival Rate
(Stage I Stomach Cancer)
>5-Year Survival Rate
(Stage II Stomach Cancer)
>5-Year Survival Rate
(All Stages of Pancreatic Cancer Combined)
CDx Diagnostics has a dedicated team of world-class imaging and artificial intelligence engineers and developers committed to pushing the edge of impossibility to create next-generation diagnostic and histocytology solutions.
©2024 CDx Diagnostics. All Rights Reserved.
